Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.05
0.00 (0.00%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Medifast Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Medifast stock has a target of 12, which predicts a 19.40% increase from the current stock price of 10.05.
Price Target: $12 (+19.40%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Medifast is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +19.40% | Feb 19, 2026 |
| DA Davidson | DA Davidson | Hold Maintains $17 → $17 | Hold | Maintains | $17 → $17 | +64.18% | Feb 19, 2025 |
| DA Davidson | DA Davidson | Sell → Hold Upgrades $17 → $17 | Sell → Hold | Upgrades | $17 → $17 | +69.15% | Nov 5, 2024 |
| DA Davidson | DA Davidson | Sell Maintains $18 | Sell | Maintains | $18 | +74.13% | Jul 22, 2024 |
| DA Davidson | DA Davidson | Hold → Sell Downgrades $25 → $18 | Hold → Sell | Downgrades | $25 → $18 | +74.13% | Jun 5, 2024 |
Financial Forecast
Revenue This Year
276.44M
from 385.79M
Decreased by -28.34%
Revenue Next Year
249.87M
from 276.44M
Decreased by -9.61%
EPS This Year
-2.00
from -1.70
EPS Next Year
-2.79
from -2.00
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 287.4M | 259.8M |
| Avg | 276.4M | 249.9M |
| Low | 268.2M | 242.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | -25.5% | -6.0% |
| Avg | -28.3% | -9.6% |
| Low | -30.5% | -12.3% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -2.08 | -2.90 |
| Avg | -2.00 | -2.79 |
| Low | -1.94 | -2.70 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.